Patients will be recruited consecutively from the rheumatology centers (as described above).
Criteria for inclusion and exclusion of patients with acute arthritis and expect arthritis from microcrystal transverse) clinical diagnosis of gout (clinical diagnosis of CPP arthritis .
Demographic variables as Lifestyles, Comorbidity, Clinical assessment (ACR / EULAR criteria)
Laboratory Ultrasound Therapies Adverse events Process outcome variables of the different management phases starting from the EULAR recommendations for the diagnosis and treatment of microcrystal arthritis (GOUT & CPPD) .Radiographic damage score (sVHe JSN score VAS pain, patient global, physician (G & C) Hyperuricemia (G) Adverse events (G & C)